Transparency in Health and Health Care in the United States

Law and Ethics
Herausgeber: Fernandez Lynch, Holly; Evans, Barbara J; Shachar, Carmel; Cohen, I Glenn

• Broschiertes Buch

Produktbeschreibung

Examines the impact of increased transparency on the legal, medical, and business structures of the American health care system.

Produktdetails

• Verlag: Cambridge University Press
• Seitenzahl: 370
• Erscheinungstermin: 6. Juni 2019
• Englisch
• Abmessung: 229mm x 213mm x 20mm
• Gewicht: 544g
• ISBN-13: 9781108456937
• ISBN-10: 1108456936
• Artikelnr.: 54392272

Inhaltsangabe

Introduction Carmel Shachar, I. Glenn Cohen, Holly Fernandez Lynch and
Barbara J. Evans; Part I. Transparency in Health and Health Care: Thematic
Issues: Introduction Abigail R. Moncrieff; 1. Smashing into windows: 'the
limits of consumer sovereignty in health care' Barry R. Furrow; 2. The
interplay of privacy and transparency in health care: the HIPAA privacy
rule as a case study Barbara J. Evans; 3. Transparency tradeoffs:
priority-setting, scarcity, and health fairness Govind Persad; 4. Slightly
hazy: transparency and the costs of too much information Oliver J. Kim;
Part II. Transparency and Informed Consent: Introduction Luke Gelinas; 5.
Transparency versus informed consent: the patient/consumer paradigms Craig
J. Konnoth; 6. Transparency and financial conflicts: the uncertain case for
sunshine Richard S. Saver; 7. Making religion transparent: the substance,
process, and efficacy of disclosing religious restrictions on care
Elizabeth Sepper; Part III. Transparency and Economics: Health Care Costs
and Billing: Introduction Kristin M. Madison; 8. Transparency on
prescription drug research expenditures: a lever for restraining pricing?
Ameet Sarpatwari, Jerry Avorn and Aaron S. Kesselheim; 9. Is pharmaceutical
price transparency an effective means to reduce high prices and wide
variations? Marc A. Rodwin; 10. Price transparency: a contracts solution
Wendy Netter Epstein; 11. Solving surprise medical bills Mark A. Hall; Part
IV. Transparency and Innovation: Introduction Holly Fernandez Lynch; 12.
Increasing the transparency of FDA review to enhance the innovation process
Rachel E. Sachs and Thomas J. Hwang; 13. Transparency and clinical trial
data sharing: legal and policy issues Barbara E. Bierer, Mark Barnes and
Rebecca Li; 14. The European Medicines Agency's approach to transparency
Stefano Marino and Spyridon Drosos; Part V. Transparency and Outcomes:
Promoting Health and Safety: Introduction Gregory Curfman; 15. The role of
transparency in promoting healthy behaviors: pros, cons, and perils of
information sharing to foster personal responsibility in health care
Anthony W. Orlando and Arnold J. Rosoff; 16. The role of transparency in
patient safety improvement Michelle M. Mello, David M. Studdert, Brahmajee
K. Nallamothu and Allen Kachalia; 17. Personal health records as a tool for
transparency in health care Sharona Hoffman; 18. Nontransparency in
electronic health record systems Jim Hawkins, Barbara J. Evans and Harlan
M. Krumholz; 19. Transparency challenges in reproductive health care Dov
Fox; Part VI. Challenges in Promoting and Measuring Transparency in Health
Care: Introduction I. Glenn Cohen; 20. ERISA as a barrier for state health
care transparency efforts Erin C. Fuse Brown and Jaime S. King; 21.
Transparency and data sharing in clinical research and Big Pharma Jennifer
E. Miller; 22. Promoting IRB transparency: about what, to whom, why, and
how? Holly Fernandez Lynch; 23. Using disclosure to regulate PBMs: the dark
side of transparency David A. Hyman and William E. Kovacic.